
BMS poaches AZ’s head of global medical affairs
pharmafile | October 1, 2010 | Appointment | Research and Development, Sales and Marketing | BMS, appointment, research and development, sales and marketing
Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK.
He joins BMS from AstraZeneca, where he has held a number of local, regional and global roles in medical affairs over the last 11 years.
His most recent role at the company was head of global medical affairs, where he was responsible for teams spanning the whole portfolio based in the US, UK and Sweden.
In his new role he will report into BMS’ chief medical officer for Europe Magnus Jaderberg.
Prior to joining the pharmaceutical industry, Dr Lones worked as a GP for 10 years, including seven years as a medical officer in the Royal Air Force, and saw active service in Saudi Arabia during the first Gulf War.
Commenting on the appointment, Frédéric Duchesne, European VP and general manager of BMS UK, said: “Bristol-Myers Squibb is recognised as having one of the healthiest pipelines in the industry, and so we are delighted to have Rick join us as medical director.
“He brings a wealth of clinical and commercial experience that will help us maximise the commercial potential of our existing and new products, and make a positive difference to the lives of patients who are fighting serious diseases.”
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …






